CUROSURF Side Effects

6543603-0 | Unevaluable Event
on Jan 19, 2010 Female patient from UNITED STATES , weighting 3.09 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: unevaluable event. Curosurf dosage: 1.75 Ml X Once Et.

6328850-5 | Haemorrhage Intracranial, Neonatal Disorder, No Therapeutic Response, Pulmonary Haemorrhage
Patient was taking Curosurf (View Usage). Patient had the following side effects: haemorrhage intracranial, neonatal disorder, no therapeutic response, pulmonary haemorrhage on Aug 25, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 2.20 lb, was diagnosed with neonatal respiratory distress syndrome, premature baby and. Curosurf dosage: 2.5 Ml/kg 1 Intratracheal. During the same period patient was treated with CAFCIT (View Cafcit Review and Cafcit Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), NOVOLIN R (View Novolin R Review and Novolin R Label ).

6231947-1 | Pulmonary Haemorrhage
Adverse event was reported on Jun 02, 2009 by a Female patient taking Curosurf (View Usage) (Dosage: ) was diagnosed with neonatal respiratory distress syndrome and. Location: BRAZIL , weighting 2.07 lb, After Curosurf was administered, patient had the following side effects: pulmonary haemorrhage. During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ).

6231946-X | Pulmonary Haemorrhage
on Jun 02, 2009 Female patient from BRAZIL , weighting 1.83 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary haemorrhage. Curosurf dosage: . During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ).


6231941-0 | Pulmonary Haemorrhage
on Jun 02, 2009 Female patient from BRAZIL , weighting 1.68 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient had the following side effects: pulmonary haemorrhage. Curosurf dosage: . During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ).

6088004-7 | Pneumothorax, Respiratory Disorder Neonatal
Patient was taking Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: pneumothorax, respiratory disorder neonatal on Feb 05, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 5.00 lb, was diagnosed with respiratory distress and. Curosurf dosage: X1, Intratracheal. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ).

5677958-6 | Pulmonary Haemorrhage
Adverse event was reported on Mar 07, 2008 by a Female patient taking Curosurf (View Usage) (Dosage: ) was diagnosed with neonatal respiratory distress syndrome and. Location: UNITED STATES , weighting 2.20 lb, Patient experienced the following unwanted or unexpected effects: pulmonary haemorrhage.

5677957-4 | Pulmonary Haemorrhage
on Mar 07, 2008 Female patient from UNITED STATES , weighting 2.30 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient had the following side effects: pulmonary haemorrhage. Curosurf dosage: . Patient was hospitalized.

5677956-2 | Pulmonary Haemorrhage
on Mar 07, 2008 Female patient from UNITED STATES , weighting 6.10 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: pulmonary haemorrhage. Curosurf dosage: .

5677955-0 | Pulmonary Haemorrhage
Patient was taking Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary haemorrhage on Mar 07, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 2.70 lb, was diagnosed with neonatal respiratory distress syndrome and. Curosurf dosage: .

5677950-1 | Pulmonary Haemorrhage
Adverse event was reported on Mar 07, 2008 by a Female patient taking Curosurf (View Usage) (Dosage: ) was diagnosed with neonatal respiratory distress syndrome and. Location: UNITED STATES , weighting 6.40 lb, Patient had the following side effects: pulmonary haemorrhage.

5565874-X | Pulmonary Haemorrhage
on Nov 29, 2007 Female patient from BRAZIL , child 0 years of age, weighting 5.40 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: pulmonary haemorrhage. Curosurf dosage: 100 Mg/kg; X1; Endotracheal. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ).

5457887-3 | Haemorrhage Neonatal, Pulmonary Haemorrhage
on Sep 07, 2007 Male patient from UNITED STATES , weighting 2.31 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage neonatal, pulmonary haemorrhage. Curosurf dosage: Once, Intratracheal. During the same period patient was treated with DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), SODIUM ACETATE (View Sodium Acetate Review and Sodium Acetate Label ). Patient was hospitalized.

5457467-X | Disseminated Intravascular Coagulation In Newborn, Haemorrhage Neonatal, Neonatal Respiratory Failure, Pulmonary Haemorrhage
Patient was taking Curosurf (View Usage). Patient had the following side effects: disseminated intravascular coagulation in newborn, haemorrhage neonatal, neonatal respiratory failure, pulmonary haemorrhage on Sep 07, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 1.52 lb, was diagnosed with neonatal respiratory distress syndrome and. Curosurf dosage: Once, Inh. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), INSULIN (View Insulin Review and Insulin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

5453422-4 | Hypotension, Hypothermia, Pulmonary Haemorrhage, Renal Failure, Respiratory Failure, Sepsis
Adverse event was reported on Sep 07, 2007 by a Female patient taking Curosurf (View Usage) (Dosage: Once, Intratracheal) was diagnosed with respiratory distress and. Location: UNITED STATES , weighting 1.28 lb, After Curosurf was administered, patient had the following side effects: hypotension, hypothermia (What is hypothermia?), pulmonary haemorrhage, renal failure, respiratory failure, sepsis (What is sepsis?).

5215173-0 | Bronchitis Pneumococcal, Condition Aggravated, Cyanosis, Emphysema, Haemorrhage, Hypercapnia, Hyperglycaemia, Hypoxia
on Jun 13, 2006 Male patient from ITALY , weighting 7055 lb, was diagnosed with respiratory distress and was treated with Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis pneumococcal, condition aggravated, cyanosis, emphysema, haemorrhage, hypercapnia, hyperglycaemia, hypoxia. Curosurf dosage: 480 Mg-intratracheal. During the same period patient was treated with VALIUM (View Valium Review and Valium Label ).

5215094-3 | Neonatal Pneumonia, Pulmonary Hypertension, Respiratory Disorder, Respiratory Failure
on May 23, 2006 Male patient from ITALY , weighting 8.82 lb, was treated with Curosurf (View Usage). Patient had the following side effects: neonatal pneumonia, pulmonary hypertension (What is pulmonary hypertension?), respiratory disorder, respiratory failure. Curosurf dosage: 480 Mg, Intratracheal. During the same period patient was treated with NITRIC OXIDE (View Nitric Oxide Review and Nitric Oxide Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ). Patient was hospitalized.

5215030-X | Cerebral Haemorrhage Neonatal, Neonatal Disorder, Neonatal Respiratory Distress Syndrome, Neonatal Respiratory Failure, Pneumothorax, Renal Failure Neonatal
Patient was taking Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: cerebral haemorrhage neonatal, neonatal disorder, neonatal respiratory distress syndrome, neonatal respiratory failure, pneumothorax, renal failure neonatal on May 23, 2006 from ITALY Additional patient health information: Male patient , weighting 2.00 lb, was diagnosed with lung disorder and. Curosurf dosage: 160 Mg, Intratracheal. During the same period patient was treated with PENICILLIN G (View Penicillin G Review and Penicillin G Label ), GENTAMYCIN GENTAMYCIN (View Gentamycin -gentamycin Review and Gentamycin -gentamycin Label ), DOPMIN DOPAMINE HYDROCHLORIDE (View Dopmin - Dopamine Hydrochloride Review and Dopmin - Dopamine Hydrochloride Label ), ADRENALINE ADRENALINE (View Adrenaline - Adrenaline Review and Adrenaline - Adrenaline Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

5212998-2 | Adrenal Disorder, Cerebral Haemorrhage, Disseminated Intravascular Coagulation, Flatulence, Hypotension, Ischaemia, Malaise
Adverse event was reported on Jul 31, 2006 by a Male patient taking Curosurf (View Usage) (Dosage: 200 Mg/kg ; 100 Mg/kg) . Location: UNITED STATES , weighting 2.36 lb, Patient experienced the following unwanted or unexpected effects: adrenal disorder, cerebral haemorrhage, disseminated intravascular coagulation, flatulence, hypotension, ischaemia, malaise.

5201133-2 | Bradycardia Neonatal, Dehydration, Excoriation, Immature Respiratory System, Metabolic Acidosis, Mucosal Hyperaemia, Neonatal Cardiac Failure, Neonatal Disorder
on Aug 10, 2006 Female patient from ITALY , weighting 1.54 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient had the following side effects: bradycardia neonatal, dehydration, excoriation, immature respiratory system, metabolic acidosis, mucosal hyperaemia, neonatal cardiac failure, neonatal disorder. Curosurf dosage: 72 Milligrams, Intratrachael. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), FLUCONASOLE (View Fluconasole Review and Fluconasole Label ), ALIKE (View Alike Review and Alike Label ).

5166389-3 | Cardio-respiratory Arrest Neonatal
on Oct 27, 2006 Male patient from UNITED STATES , weighting 3.31 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: cardio-respiratory arrest neonatal. Curosurf dosage: 240mg-intratracheal - Twice. During the same period patient was treated with BENZYLPENICILLIN (BENZYLPENICILLIN) (View Benzylpenicillin (benzylpenicillin) Review and Benzylpenicillin (benzylpenicillin) Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

5166382-0 | Cardio-respiratory Arrest Neonatal
Patient was taking Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest neonatal on Oct 27, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 3.31 lb, was diagnosed with neonatal respiratory distress syndrome and. Curosurf dosage: 240mg-intratracheal - Twice. During the same period patient was treated with BENZYLPENICILLIN (BENZYLPENICILLIN (View Benzylpenicillin (benzylpenicillin Review and Benzylpenicillin (benzylpenicillin Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

5090801-1 | Bradycardia Neonatal, Metabolic Acidosis, Neonatal Disorder, Pneumothorax
Adverse event was reported on Aug 10, 2006 by a Female patient taking Curosurf (View Usage) (Dosage: 72 Milligrams-intratracheal) was diagnosed with respiratory distress and. Location: ITALY , weighting 1.54 lb, Patient had the following side effects: bradycardia neonatal, metabolic acidosis, neonatal disorder, pneumothorax. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), FKYCIBALIKE (View Fkycibalike Review and Fkycibalike Label ).

5074473-8 | Adrenal Cortical Insufficiency, Capillary Leak Syndrome, Cerebral Haemorrhage Neonatal, Disseminated Intravascular Coagulation, Flatulence, Intestinal Ischaemia, Neonatal Hypotension
on Jul 28, 2006 Male patient from UNITED STATES , weighting 2.36 lb, was diagnosed with respiratory distress and was treated with Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: adrenal cortical insufficiency, capillary leak syndrome, cerebral haemorrhage neonatal, disseminated intravascular coagulation, flatulence, intestinal ischaemia, neonatal hypotension. Curosurf dosage: 200 Mg/kg.

5034674-1 | Bradycardia Neonatal, Dyspnoea, Metabolic Acidosis, Neonatal Disorder, Neonatal Tachypnoea, Oxygen Saturation Decreased, Pneumothorax
on Jun 16, 2006 Female patient from ITALY , weighting 1.54 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia neonatal, dyspnoea, metabolic acidosis, neonatal disorder, neonatal tachypnoea, oxygen saturation decreased, pneumothorax. Curosurf dosage: 72 Milligrams-intratracheal. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), FKYCIBAZIKE (View Fkycibazike Review and Fkycibazike Label ).

5033537-5 | Bradycardia, Condition Aggravated, Metabolic Acidosis, Pneumothorax
Patient was taking Curosurf (View Usage). Patient had the following side effects: bradycardia, condition aggravated, metabolic acidosis, pneumothorax on Jun 16, 2006 from ITALY Additional patient health information: Female patient , weighting 1.54 lb, was diagnosed with respiratory distress and. Curosurf dosage: 72 Milligrams-intratrachael. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), FKYCIBAZIKE (View Fkycibazike Review and Fkycibazike Label ).

5019445-4 | Pneumonia, Pulmonary Hypertension, Respiratory Disorder
Adverse event was reported on May 23, 2006 by a Male patient taking Curosurf (View Usage) (Dosage: 480mg, Intratracheal) . Location: ITALY , weighting 8.82 lb, After Curosurf was administered, patient had the following side effects: pneumonia (What is pneumonia?), pulmonary hypertension (What is pulmonary hypertension?), respiratory disorder. Patient was hospitalized.

5019443-0 | Cerebral Haemorrhage, Infection, Lung Disorder, Neonatal Pneumonia, Neonatal Respiratory Distress Syndrome, Pneumothorax, Pulmonary Haemorrhage, Renal Failure Neonatal
on May 23, 2006 Male patient from ITALY , weighting 2.00 lb, was diagnosed with lung disorder and was treated with Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, infection (What is infection?), lung disorder, neonatal pneumonia, neonatal respiratory distress syndrome, pneumothorax, pulmonary haemorrhage, renal failure neonatal. Curosurf dosage: 160 Mg, Intratracheal. During the same period patient was treated with PENICILLIN G (View Penicillin G Review and Penicillin G Label ), GENTAMYCIN GENTAMYCIN (View Gentamycin - Gentamycin Review and Gentamycin - Gentamycin Label ), DOPMIN DOPAMINE HYDROCHLORIDE (View Dopmin - Dopamine Hydrochloride Review and Dopmin - Dopamine Hydrochloride Label ), ADRENALINE ADRENALINE (View Adrenaline - Adrenaline Review and Adrenaline - Adrenaline Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ).

5002620-2 | Cerebral Haemorrhage Neonatal, Neonatal Respiratory Failure, Pneumothorax, Renal Failure Neonatal
on May 03, 2006 Male patient from ITALY , weighting 2.00 lb, was diagnosed with lung disorder and was treated with Curosurf (View Usage). Patient had the following side effects: cerebral haemorrhage neonatal, neonatal respiratory failure, pneumothorax, renal failure neonatal. Curosurf dosage: 160 Mg, Intratracheal. During the same period patient was treated with PENICILLIN G (View Penicillin G Review and Penicillin G Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), DOPMIN DOPAMINE HYDROCHLORIDE (View Dopmin - Dopamine Hydrochloride Review and Dopmin - Dopamine Hydrochloride Label ), ADRENALINE (View Adrenaline Review and Adrenaline Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

5002619-6 | Neonatal Respiratory Failure, Pulmonary Hypertension
Patient was taking Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: neonatal respiratory failure, pulmonary hypertension (What is pulmonary hypertension?) on May 03, 2006 from ITALY Additional patient health information: Male patient , weighting 8.82 lb, . Curosurf dosage: 480mg, Intratracheal. Patient was hospitalized.

4984580-3 | Bradycardia Neonatal, Cardiopulmonary Failure, Neonatal Asphyxia, Neonatal Disorder, Neonatal Respiratory Distress Syndrome, Respiratory Disorder Neonatal
Adverse event was reported on Apr 10, 2006 by a Male patient taking Curosurf (View Usage) (Dosage: Intratracheal) was diagnosed with neonatal respiratory distress syndrome and. Location: ITALY , weighting 5.51 lb, Patient experienced the following unwanted or unexpected effects: bradycardia neonatal, cardiopulmonary failure, neonatal asphyxia, neonatal disorder, neonatal respiratory distress syndrome, respiratory disorder neonatal.

4946028-4 | Pulmonary Haemorrhage
on Aug 22, 2005 Male patient from UNITED STATES , weighting 1.52 lb, was diagnosed with acute respiratory distress syndrome and was treated with Curosurf (View Usage). Patient had the following side effects: pulmonary haemorrhage. Curosurf dosage: 2.5ml, Endotracheally. During the same period patient was treated with AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), DOPAMINE (View Dopamine Review and Dopamine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

4946010-7 | Pulmonary Haemorrhage
on Aug 22, 2005 Male patient from UNITED STATES , weighting 1.52 lb, was diagnosed with acute respiratory distress syndrome and was treated with Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: pulmonary haemorrhage. Curosurf dosage: 2.5ml, Endotracteally. During the same period patient was treated with AMPCILLIN (View Ampcillin Review and Ampcillin Label ), GEMTAMICINE (View Gemtamicine Review and Gemtamicine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

4946004-1 | Pulmonary Haemorrhage
Patient was taking Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary haemorrhage on Aug 22, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 1.41 lb, was diagnosed with neonatal respiratory distress syndrome and. Curosurf dosage: 2.5ml, Endotracteally. During the same period patient was treated with AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), DOPAMINE (View Dopamine Review and Dopamine Label ).

4847799-8 | C-reactive Protein Increased, Condition Aggravated, Pneumococcal Infection
Adverse event was reported on Nov 18, 2005 by a Male patient taking Curosurf (View Usage) (Dosage: Intratracheal) was diagnosed with acute respiratory distress syndrome and. Location: ITALY , weighting 7055 lb, Patient had the following side effects: c-reactive protein increased, condition aggravated, pneumococcal infection.

4768088-6 | Cardio-respiratory Arrest, Pulmonary Haemorrhage
on Sep 12, 2005 Male patient from UNITED STATES , weighting 1.41 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: cardio-respiratory arrest, pulmonary haemorrhage. Curosurf dosage: 2.5ml, Endotracheally. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), DOPAMINE (View Dopamine Review and Dopamine Label ).

4764395-1 | Cardio-respiratory Arrest Neonatal, Neonatal Disorder, Pulmonary Haemorrhage
on Aug 22, 2005 Male patient from UNITED STATES , weighting 1.41 lb, was diagnosed with acute respiratory distress syndrome and was treated with Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest neonatal, neonatal disorder, pulmonary haemorrhage. Curosurf dosage: 2.5 Ml, Endotracheally. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), DOPAMINE (View Dopamine Review and Dopamine Label ).

4746275-0 | Adrenal Insufficiency Neonatal, Anaemia Neonatal, Fungal Sepsis, Necrotising Enterocolitis Neonatal, Neonatal Cholestasis, Neonatal Disorder, Pulmonary Embolism, Pulmonary Haemorrhage, Staphylococcal Infection
Patient was taking Curosurf (View Usage). Patient had the following side effects: adrenal insufficiency neonatal, anaemia neonatal, fungal sepsis, necrotising enterocolitis neonatal, neonatal cholestasis, neonatal disorder, pulmonary embolism (What is pulmonary embolism?), pulmonary haemorrhage, staphylococcal infection (What is staphylococcal infection?) on Jul 22, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 1.48 lb, was diagnosed with neonatal respiratory distress syndrome and. Curosurf dosage: . During the same period patient was treated with BUNK (View Bunk Review and Bunk Label ). Patient was hospitalized.

4746274-9 | Adrenal Insufficiency Neonatal, Anaemia Neonatal, Bacteraemia, Hypertension Neonatal, Neonatal Disorder, Pneumothorax, Pulmonary Embolism, Pulmonary Haemorrhage
Adverse event was reported on Jul 22, 2005 by a Male patient taking Curosurf (View Usage) (Dosage: ) was diagnosed with neonatal respiratory distress syndrome and. Location: UNITED STATES , weighting 1.51 lb, After Curosurf was administered, patient had the following side effects: adrenal insufficiency neonatal, anaemia neonatal, bacteraemia, hypertension neonatal, neonatal disorder, pneumothorax, pulmonary embolism (What is pulmonary embolism?), pulmonary haemorrhage. Patient was hospitalized.

4746273-7 | Neonatal Disorder, Pulmonary Haemorrhage
on Jul 22, 2005 Male patient from UNITED STATES , weighting 1.40 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient experienced the following unwanted or unexpected effects: neonatal disorder, pulmonary haemorrhage. Curosurf dosage: . During the same period patient was treated with BUNK (View Bunk Review and Bunk Label ).

4734708-5 | Neonatal Disorder, Pneumothorax, Pulmonary Embolism, Pulmonary Haemorrhage
on Jul 22, 2005 Male patient from UNITED STATES , weighting 1.51 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Curosurf (View Usage). Patient had the following side effects: neonatal disorder, pneumothorax, pulmonary embolism (What is pulmonary embolism?), pulmonary haemorrhage. Curosurf dosage: . Patient was hospitalized.

4734550-5 | Neonatal Disorder, Pulmonary Haemorrhage
Patient was taking Curosurf (View Usage). After Curosurf was administered, patient had the following side effects: neonatal disorder, pulmonary haemorrhage on Jul 22, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 1.39 lb, was diagnosed with neonatal respiratory distress syndrome and. Curosurf dosage: .

4734539-6 | Neonatal Disorder, Pulmonary Embolism, Pulmonary Haemorrhage
Adverse event was reported on Jul 22, 2005 by a Male patient taking Curosurf (View Usage) (Dosage: ) was diagnosed with neonatal respiratory distress syndrome and. Location: UNITED STATES , weighting 1.52 lb, Patient experienced the following unwanted or unexpected effects: neonatal disorder, pulmonary embolism (What is pulmonary embolism?), pulmonary haemorrhage. Patient was hospitalized.